• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估纳米载体在腹水和转移环境中递送效果的多细胞卵巢癌模型

Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments.

作者信息

Winter Stephen J, Miller Hunter A, Steinbach-Rankins Jill M

机构信息

School of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

出版信息

Pharmaceutics. 2021 Nov 8;13(11):1891. doi: 10.3390/pharmaceutics13111891.

DOI:10.3390/pharmaceutics13111891
PMID:34834307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8625169/
Abstract

A novel multicellular model composed of epithelial ovarian cancer and fibroblast cells was developed as an in vitro platform to evaluate nanovector delivery and ultimately aid the development of targeted therapies. We hypothesized that the inclusion of peptide-based scaffold (PuraMatrix) in the spheroid matrix, to represent in vivo tumor microenvironment alterations along with metastatic site conditions, would enhance spheroid cell growth and migration and alter nanovector transport. The model was evaluated by comparing the growth and migration of ovarian cancer cells exposed to stromal cell activation and tissue hypoxia. Fibroblast activation was achieved via the TGF-β1 mediated pathway and tissue hypoxia via 3D spheroids incubated in hypoxia. Surface-modified nanovector transport was assessed via fluorescence and confocal microscopy. Consistent with previous in vivo observations in ascites and at distal metastases, spheroids exposed to activated stromal microenvironment were denser, more contractile and with more migratory cells than nonactivated counterparts. The hypoxic conditions resulted in negative radial spheroid growth over 5 d compared to a radial increase in normoxia. Nanovector penetration attenuated in PuraMatrix regardless of surface modification due to a denser environment. This platform may serve to evaluate nanovector transport based on ovarian ascites and metastatic environments, and longer term, it provide a means to evaluate nanotherapeutic efficacy.

摘要

构建了一种由上皮性卵巢癌和成纤维细胞组成的新型多细胞模型,作为体外平台来评估纳米载体递送,并最终助力靶向治疗的开发。我们假设,在球体基质中加入基于肽的支架(PuraMatrix)以模拟体内肿瘤微环境变化及转移部位情况,会增强球体细胞的生长和迁移,并改变纳米载体的转运。通过比较暴露于基质细胞活化和组织缺氧条件下的卵巢癌细胞的生长和迁移情况,对该模型进行了评估。通过TGF-β1介导的途径实现成纤维细胞活化,通过在缺氧条件下培养三维球体实现组织缺氧。通过荧光和共聚焦显微镜评估表面修饰的纳米载体转运。与先前在腹水和远处转移的体内观察结果一致,与未活化的对应物相比,暴露于活化基质微环境的球体密度更高、收缩性更强且迁移细胞更多。与正常氧条件下球体半径增加相比,缺氧条件导致球体在5天内呈负向径向生长。由于环境更致密,无论表面修饰如何,纳米载体在PuraMatrix中的渗透都会减弱。该平台可用于基于卵巢腹水和转移环境评估纳米载体转运,从长远来看,它提供了一种评估纳米治疗效果的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/a9ce97074859/pharmaceutics-13-01891-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/56236d5992b9/pharmaceutics-13-01891-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/2477d1030453/pharmaceutics-13-01891-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/c8a9ca687ad3/pharmaceutics-13-01891-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/7ad92338b456/pharmaceutics-13-01891-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/892474a5f5d3/pharmaceutics-13-01891-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/9184a68b4003/pharmaceutics-13-01891-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/a9ce97074859/pharmaceutics-13-01891-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/56236d5992b9/pharmaceutics-13-01891-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/2477d1030453/pharmaceutics-13-01891-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/c8a9ca687ad3/pharmaceutics-13-01891-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/7ad92338b456/pharmaceutics-13-01891-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/892474a5f5d3/pharmaceutics-13-01891-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/9184a68b4003/pharmaceutics-13-01891-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/8625169/a9ce97074859/pharmaceutics-13-01891-g007.jpg

相似文献

1
Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments.用于评估纳米载体在腹水和转移环境中递送效果的多细胞卵巢癌模型
Pharmaceutics. 2021 Nov 8;13(11):1891. doi: 10.3390/pharmaceutics13111891.
2
Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.间皮细胞与肿瘤细胞相互作用,以在腹腔积液中形成卵巢癌多细胞球体。
Clin Exp Metastasis. 2016 Dec;33(8):839-852. doi: 10.1007/s10585-016-9821-y. Epub 2016 Sep 9.
3
Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype.卵巢癌细胞形成紧密球体与收缩行为和侵袭性表型相关。
Int J Cancer. 2009 May 1;124(9):2060-70. doi: 10.1002/ijc.24188.
4
A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery.一种用于研究肿瘤-基质相互作用和药物发现的新型基质成纤维细胞调控的3D肿瘤球体模型
J Vis Exp. 2020 Feb 28(156). doi: 10.3791/60660.
5
Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4.来源于 nectin-4 的合成肽抑制卵巢癌细胞球体形成。
Int J Mol Sci. 2020 Jun 30;21(13):4637. doi: 10.3390/ijms21134637.
6
TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.转化生长因子β信号通路调节卵巢癌腹水来源球体中的上皮-间质可塑性。
Endocr Relat Cancer. 2016 Mar;23(3):147-59. doi: 10.1530/ERC-15-0383. Epub 2015 Dec 8.
7
Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.腹水助力卵巢癌细胞的转移之旅:各种细胞成分的协同作用。
Int J Mol Sci. 2022 Apr 15;23(8):4383. doi: 10.3390/ijms23084383.
8
[Characterization of a 3-dimensional tuberculosis spheroid model constructed using human monocytic THP-1 cells and ].[使用人单核细胞THP-1细胞构建的三维结核球模型的表征及] (注:原文句子不完整)
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Dec 20;43(12):2095-2102. doi: 10.12122/j.issn.1673-4254.2023.12.14.
9
The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.卵巢癌细胞球的大小和形状对耐药性和迁移的影响。
Gynecol Oncol. 2020 Nov;159(2):563-572. doi: 10.1016/j.ygyno.2020.09.002. Epub 2020 Sep 18.
10
The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.转铁蛋白靶向的基于聚乙二醇-磷脂的混合胶束共递送紫杉醇和姜黄素对三维球体和体内肿瘤中耐药卵巢癌的影响
Eur J Pharm Biopharm. 2014 Oct;88(2):539-50. doi: 10.1016/j.ejpb.2014.07.001. Epub 2014 Jul 10.

引用本文的文献

1
Hybrid Endometrial-Derived Hydrogels: Human Organoid Culture Models and In Vivo Perspectives.混合子宫内膜衍生水凝胶:人体类器官培养模型和体内研究视角。
Adv Healthc Mater. 2024 Apr;13(11):e2303838. doi: 10.1002/adhm.202303838. Epub 2023 Nov 27.
2
Heterotypic tumor spheroids: a platform for nanomedicine evaluation.异质肿瘤球体:一种用于评估纳米医学的平台。
J Nanobiotechnology. 2023 Aug 2;21(1):249. doi: 10.1186/s12951-023-02021-y.
3
Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.

本文引用的文献

1
Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment.三维肿瘤球体作为可靠研究金纳米颗粒与多西他赛联合治疗的工具
Cancers (Basel). 2021 Mar 23;13(6):1465. doi: 10.3390/cancers13061465.
2
Dendrimer-decorated nanogels: Efficient nanocarriers for biodistribution and chemotherapy of ovarian carcinoma.树枝状聚合物修饰的纳米凝胶:用于卵巢癌生物分布和化疗的高效纳米载体。
Bioact Mater. 2021 Mar 13;6(10):3244-3253. doi: 10.1016/j.bioactmat.2021.02.031. eCollection 2021 Oct.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
卵巢癌球体形成和腹膜转移:基质和免疫成分的作用。
Int J Mol Sci. 2022 Jun 1;23(11):6215. doi: 10.3390/ijms23116215.
4
Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers' Performance In Vitro and In Vivo.靶向癌细胞紧密连接增强基于聚乳酸-羟基乙酸共聚物的光热敏化剂的体内外性能。
Pharmaceutics. 2021 Dec 26;14(1):43. doi: 10.3390/pharmaceutics14010043.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Evaluation of Nanoparticle Penetration in the Tumor Spheroid Using Two-Photon Microscopy.使用双光子显微镜评估纳米颗粒在肿瘤球状体中的渗透情况。
Biomedicines. 2020 Dec 24;9(1):10. doi: 10.3390/biomedicines9010010.
5
How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer.自噬如何塑造卵巢癌的肿瘤微环境
Front Oncol. 2020 Dec 7;10:599915. doi: 10.3389/fonc.2020.599915. eCollection 2020.
6
Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy.精准医学中的纳米颗粒用于卵巢癌:从化疗到免疫治疗。
Int J Pharm. 2020 Dec 15;591:119986. doi: 10.1016/j.ijpharm.2020.119986. Epub 2020 Oct 16.
7
In Vivo and In Vitro Anticancer Activity of Doxorubicin-loaded DNA-AuNP Nanocarrier for the Ovarian Cancer Treatment.载阿霉素的DNA-金纳米颗粒纳米载体对卵巢癌治疗的体内外抗癌活性
Cancers (Basel). 2020 Mar 9;12(3):634. doi: 10.3390/cancers12030634.
8
Correction: Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.更正:异型癌相关成纤维细胞-肿瘤球体促进卵巢癌早期腹膜转移。
J Exp Med. 2019 Oct 7;216(10):2448. doi: 10.1084/jem.2018076508222019c.
9
In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy.载紫杉醇叶酸修饰的 PLGA 纳米粒的体外评价及其用于卵巢癌治疗的研究。
Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110038. doi: 10.1016/j.msec.2019.110038. Epub 2019 Jul 30.
10
Systematic Identification of Characteristic Genes of Ovarian Clear Cell Carcinoma Compared with High-Grade Serous Carcinoma Based on RNA-Sequencing.基于 RNA 测序的卵巢透明细胞癌与高级别浆液性癌特征基因的系统鉴定。
Int J Mol Sci. 2019 Sep 4;20(18):4330. doi: 10.3390/ijms20184330.